Overview
Short Course: October 30 | Virtual
Short Course: November 2 | Virtual
Meeting: November 7-8 | In-Person
The DIA Canada Annual Meeting will deliver a comprehensive overview of the current pharmaceutical, medical device, and/or diagnostic landscapes in Canada, while sharing insights into Canada’s broader role in global healthcare product development and is separated into three tracks: Regulatory, Clinical and Pharmacovigilance. This meeting will connect attendees with leaders and experts in academia and those involved in the regulatory, clinical, and pharmacovigilance functional areas in the pharmaceutical and medical device industry to explore best practices, lessons learned, and problem-solving strategies effecting stakeholders in Canada.
Immerse yourself in a dynamic learning experience where your career's potential knows no bounds. Discover the latest updates and priorities directly from Health Canada and supercharge your daily work with newfound knowledge. Dive into the world of artificial intelligence and machine learning, uncovering both challenges and opportunities while staying ahead of evolving regulatory expectations. Additionally, our comprehensive program covers a spectrum of vital topics, including advanced therapies, equitable drug development, the recent ICH E6 R3 revisions, what’s new and where we stand with nitrosamine impurities, data transparency, mastering Good Pharmacovigilance Practices (GVP), best practices for decentralized clinical trials, and the secrets to making swift, informed decisions. Don't miss out on this unparalleled opportunity to elevate your career to new heights!
Want to know more? View the Track Chair Video below to hear about the great content!
Need Approval in Order to Attend?
Download and fill out our Justification Letter to demand to supervisor why this is a must-attend event.
Participant Testimonials
Very insightful conference. Time well invested. – Thierry Page, Executive VP, COO, Starpax Biopharma Inc.
The best conference for Canadian content of 2022. – Patricia Smith, Director, Regulatory Affairs, QA and PV, Otsuka Canada Pharmaceutical Inc.
Program Committee
-
Maria Anillo Regulatory Affairs Project Manager
AstraZeneca Canada Inc., Canada -
Marcia Bailey, BSN, MHS, RN Safety Evaluation and Risk Management Scientific Director
GSK, Canada -
Vatche Bartekian, MSc President
Vantage BioTrials, Canada -
Mandy Collier Director, Health Products and Food Branch
Health Canada, Canada -
Melanie Cote, MS Senior Manager, Global Regulatory Affairs
Otsuka Pharmaceutical Development & Commercialization Inc., Canada -
My Dang, MBA Director/Consultant, Regulatory Affairs
Cencora, Canada -
Tharany Ganesh, MSc Head, Regulatory Affairs
AstraZeneca Canada Inc., Canada -
Lorella Garofalo, PhD Head of Regulatory Sciences
Pfizer Canada ULC, Canada -
Marie-France Goyer, MSc Director, Clinical Operations
Abcellera, Canada -
Brenda Gryfe, MSc Regulatory Consultant
Brenda Gryfe Regulatory Consulting, Canada -
Oxana Iliach, PhD Senior Director Regulatory Strategy
Certara, Canada -
Agnes Jankowicz, MS Vice President, Pharmacovigilance
ClaroPV, Canada -
Nadiya Jirova, MSc Manager, Bureau of Biologics, Radiopharmaceuticals and Self-Care Products
Health Canada, Canada -
Yatika Kohli, PhD, MBA Chief Compliance and Strategy Officer
NoNO Inc, Canada -
Nadia Latif, MS Senior Manager, Pharmacovigilance
Ipsen Biopharmaceuticals Canada Inc., Canada -
Myriam Salem, MSc Good Pharmacovigilance Practices National Coordinator
Health Canada, Canada -
Marcia Sam Senior Manager, Regulatory Affairs
Regeneron Canada Company, Canada -
Vanessa Zapata Associate Director, Regional Pharmacovigilance Officer
Merck Canada Inc., Canada -
Zohra Douida, MPharm, MS, MSc Head, Regulatory Affairs Canada
Indivior Canada Inc., Canada -
Amber McLeod, PhD Immunology, Virology, and Specialty Head, Regulatory Affairs
Abbvie Corporation, Canada -
Representative Invited Irish Dental Association, Ireland
Have an account?